Exhibit 4.1


 


THE SECURITIES REPRESENTED BY THIS CERTIFICATE
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “1933
ACT”), OR ANY STATE SECURITIES LAWS AND NEITHER SUCH SHARES NOR ANY INTEREST
THEREIN MAY BE OFFERED, SOLD, PLEDGED, ASSIGNED OR OTHERWISE TRANSFERRED
UNLESS (1) A REGISTRATION STATEMENT WITH RESPECT THERETO IS EFFECTIVE
UNDER THE 1933 ACT AND ANY APPLICABLE STATE SECURITIES LAWS, OR (2) PURSUANT
TO AN EXEMPTION FROM REGISTRATION UNDER THE 1933 ACT.


 


IN ADDITION, A PREFERRED STOCK PURCHASE AGREEMENT
DATED AS OF DECEMBER 22, 2005 (THE “PURCHASE AGREEMENT”), A COPY OF WHICH MAY BE
OBTAINED FROM THE COMPANY AT ITS PRINCIPAL EXECUTIVE OFFICE, CONTAINS CERTAIN
ADDITIONAL AGREEMENTS BETWEEN THE PARTIES WITH RESPECT TO THIS WARRANT.


 


Corgenix
Medical Corporation


 


(Form of)
COMMON STOCK PURCHASE WARRANT


 


	
  Number of Shares: 5,000,000.0

  	
   

  	
  Holder: Barron Partners LP

  
	
   

  	
   

  	
  c/o Barron Capital Advisors LLC

  
	
   

  	
   

  	
   

  
	
  Original Issue Date: December 28, 2005

  	
   

  	
  Managing Partner

  
	
   

  	
   

  	
  Attn: Andrew Barron Worden

  
	
   

  	
   

  	
  730 Fifth Avenue, 9th Floor

  
	
   

  	
   

  	
   

  
	
  Expiration Date: December 28, 2010

  	
   

  	
  New York NY 10019

  
	
   

  	
   

  	
  tel 212-659-7790

  
	
   

  	
   

  	
   

  
	
  Exercise Price per Share: $              

  	
   

  	
  fax 646-607-2223

  



 


Corgenix Medical
Corporation a company organized and existing under the laws of the State of
Nevada (the “Company”), hereby certifies
that, for value received, BARRON PARTNERS LP,
or its registered assigns (the “Warrant Holder”),
is entitled, subject to the terms set forth below, to purchase from the Company
up to Five Million (5,000,000.0) shares (as adjusted from time to time as
provided in Section 7, the “Warrant Shares”)
of common stock, $.001 par value (the “Common Stock”),
of the Company at a price of                   
($      ) per Warrant Share (as adjusted from
time to time as provided in Section 7, the “Exercise
Price”), at any time and from time to time from and after the
date thereof and through and including 5:00 p.m.  New York City time on December 28, 2010
(or eighteen months after effectiveness of a Registration Statement subsequent
to the issuance hereof (such eighteen months to be extended by one month for
each 


 





















 


month or portion of a
month during which a Registration Statement’s effectiveness has lapsed or been
suspended), whichever is longer) (the “Expiration Date”), and subject to the
following terms and conditions:


 


1.                                       Registration of Warrant.  The Company shall register this Warrant upon
records to be maintained by the Company for that purpose (the “Warrant Register”), in the name of
the record Warrant Holder hereof from time to time.  The Company may deem and treat the registered
Warrant Holder of this Warrant as the absolute owner hereof for the purpose of
any exercise hereof or any distribution to the Warrant Holder, and for all
other purposes, and the Company shall not be affected by notice to the
contrary.


 


2.                                       Investment Representation.  The Warrant Holder by accepting this Warrant
represents that the Warrant Holder is acquiring this Warrant for its own
account or the account of an affiliate for investment purposes and not with the
view to any offering or distribution and that the Warrant Holder will not sell
or otherwise dispose of this Warrant or the underlying Warrant Shares in
violation of applicable securities laws. 
The Warrant Holder acknowledges that the certificates representing any
Warrant Shares will bear a legend indicating that they have not been registered
under the United States Securities Act of 1933, as amended (the “1933 Act”) and may not be sold by
the Warrant Holder except pursuant to an effective registration statement or
pursuant to an exemption from registration requirements of the 1933 Act and in
accordance with federal and state securities laws. “Person”
means an individual, partnership, firm, limited liability company, trust, joint
venture, association, corporation, or any other legal entity.


 


3.                                       Validity of Warrant and Issue of Shares.   The Company represents and warrants that
this Warrant has been duly authorized and validly issued.  The Company does not currently have enough common
shares authorized to satisfy the exercise of this Warrant.  Within 90 days after the date hereof, the
Company will call a special meeting of the shareholders of the Company to
approve an amendment to the Articles of Incorporation increasing the number of
authorized shares of common stock from the current 40,000,000 to 100,000,000
(the “Share Increase Amendment”). 
Subject to the Company complying with the preceding sentence, pending
adoption of the Share Increase Amendment, the Holder hereby covenants and
agrees that under no circumstances will it seek to exercise any of the Warrants
until March 31, 2006.


 


4.                                       Registration of Transfers and Exchange of Warrants.


 


(a)                                  Subject
to compliance with the legend set forth on the face of this Warrant, the Company
shall register the transfer of any portion of this Warrant in the Warrant
Register, upon surrender of this Warrant with the Form of Assignment
attached hereto duly completed and signed, to the Company at the office
specified in or pursuant to Section 12. 
Upon any such registration or transfer, a new warrant to purchase Common
Stock, in substantially the form of this Warrant (any such new warrant, a “New Warrant”), evidencing the
portion of this Warrant so transferred shall be issued to the transferee and a
New Warrant evidencing the remaining portion of this Warrant not so
transferred, if any, shall be issued to the transferring Warrant Holder.  The acceptance of the New Warrant by the
transferee thereof shall be deemed the acceptance of such transferee of all of
the rights and obligations of a Warrant Holder of a Warrant.


 


2





















 


(b)                                 This
Warrant is exchangeable, upon the surrender hereof by the Warrant Holder to the
office of the Company specified in or pursuant to Section 12 for one or
more New Warrants, evidencing in the aggregate the right to purchase the number
of Warrant Shares which may then be purchased hereunder.  Any such New Warrant will be dated the date
of such exchange.


 


5.                                       Exercise of Warrants.


 


(a)                                  Upon
surrender of this Warrant with the Form of Election to Purchase attached
hereto duly completed and signed to the Company, at its address set forth in Section 12,
and upon payment and delivery of the Exercise Price per Warrant Share
multiplied by the number of Warrant Shares that the Warrant Holder intends to
purchase hereunder, in lawful money of the United States of America, in cash or
by certified or official bank check or checks, to the Company, all as specified
by the Warrant Holder in the Form of Election to Purchase, the Company
shall promptly (but in no event later than 7 business days after the Date of
Exercise (as defined herein)) issue or cause to be issued and cause to be
delivered to or upon the written order of the Warrant Holder and in such name
or names as the Warrant Holder may designate (subject to the restrictions on
transfer described in the legend set forth on the face of this Warrant), a
certificate for the Warrant Shares issuable upon such exercise, with such
restrictive legend as required by the 1933 Act. 
Any person so designated by the Warrant Holder to receive Warrant Shares
shall be deemed to have become holder of record of such Warrant Shares as of
the Date of Exercise of this Warrant.


 


(b)                                 A
“Date of Exercise” means the date on which the Company shall have received (i) this
Warrant (or any New Warrant, as applicable), with the Form of Election to
Purchase attached hereto (or attached to such New Warrant) appropriately
completed and duly signed, and (ii) payment of the Exercise Price for the
number of Warrant Shares so indicated by the Warrant Holder to be purchased.


 


(c)                                  This
Warrant shall be exercisable at any time and from time to time for such number
of Warrant Shares as is indicated in the attached Form of Election To Purchase.  If less than all of the Warrant Shares which
may be purchased under this Warrant are exercised at any time, the Company
shall issue or cause to be issued, at its expense, a New Warrant evidencing the
right to purchase the remaining number of Warrant Shares for which no exercise
has been evidenced by this Warrant.


 


(d)                                 (i)  Notwithstanding
anything contained herein to the contrary, but subject to Section 6, Section 5(e),
and the second sentence of Section 2 of this Warrant, the holder of this
Warrant may, at its election exercised in its sole discretion, exercise this
Warrant in whole or in part and, in lieu of making the cash payment otherwise
contemplated to be made to the Company upon such exercise in payment of the
Aggregate Exercise Price, elect instead to receive upon such exercise the “Net Number” of shares of Common Stock determined according
to the following formula (a “Cashless Exercise”):


 


Net Number = (A x (B - C))/B


 


(ii)                                  For purposes of the foregoing formula:


 


3





















 


A= the total number shares with
respect to which this Warrant is then being exercised.


 


B= the last reported sale price
(as reported by Bloomberg) of the Common Stock on the trading day immediately
preceding the date of the Exercise Notice.


 


C= the Warrant Exercise Price
then in effect at the time of such exercise.


 


(e)                                  The holder of this Warrant agrees not to elect a
Cashless Exercise for a period of six (6) months. The holder of this
Warrant also agrees not to elect a Cashless Exercise so long as there is an
effective registration statement for the Warrant Shares.


 


6.                                       Maximum Exercise.  The Warrant Holder shall not be entitled to
exercise this Warrant on a Date of Exercise in connection with that number of
shares of Common Stock which would be in excess of the sum of (i) the
number of shares of Common Stock beneficially owned by the Warrant Holder and
its affiliates on an exercise date, and (ii) the number of shares of
Common Stock issuable upon the exercise of this Warrant with respect to which
the determination of this limitation is being made on an exercise date, which
would result in beneficial ownership by the Warrant Holder and its affiliates
of more than 4.9% of the outstanding shares of Common Stock on such date.  This Section 6 may be waived or amended
only with the consent of the Holder and the consent of holders of a majority of
the shares of outstanding Common Stock of the Company who are not
Affiliates.  For the purposes of the
immediately preceding sentence, the term “Affiliate” shall mean any person: (a) that
directly, or indirectly through one or more intermediaries, controls, or is
controlled by, or is under common control with, the Company; or (b) who
beneficially owns (i) any shares of the Company’s Series A Convertible
Preferred Stock, (ii) the Company’s Common Stock Purchase Warrant        
or Common Stock Purchase Warrant        ,
each dated December 28, 2005, or (iii) this Warrant.  For the purposes of the immediately preceding
sentence, beneficial ownership shall be determined in accordance with Section 13(d) of
the Securities Exchange Act of 1934, as amended, and Regulation 13d-3
thereunder.


 


7.                                       Adjustment of Exercise Price and Number of Shares.  The character of the shares of stock or other
securities at the time issuable upon exercise of this Warrant and the Exercise
Price therefore, are subject to adjustment upon the occurrence of the following
events, and all such adjustments shall be cumulative:


 


(a)                                  Adjustment for Stock Splits, Stock Dividends, Recapitalizations, Etc.  The Exercise Price of this Warrant and the
number of shares of Common Stock or other securities at the time issuable upon
exercise of this Warrant shall be appropriately adjusted to reflect any stock
dividend, stock split, combination of shares, reclassification,
recapitalization or other similar event affecting the number of outstanding
shares of stock or securities.


 


(b)                                 Adjustment for Reorganization, Consolidation, Merger, Etc.  In case of any consolidation or merger of the
Company with or into any other corporation, entity or person, or any other
corporate reorganization, in which the Company shall not be the continuing or
surviving entity of such consolidation, merger or reorganization (any such
transaction being hereinafter referred to as a “Reorganization”), then,
in each case, the holder of this Warrant, on 


 


4





















 


exercise hereof at any time after the consummation or
effective date of such Reorganization (the “Effective
Date”), shall receive, in lieu of the shares of stock or other
securities at any time issuable upon the exercise of the Warrant issuable on
such exercise prior to the Effective Date, the stock and other securities and
property (including cash) to which such holder would have been entitled upon
the Effective Date if such holder had exercised this Warrant immediately prior
thereto (all subject to further adjustment as provided in this Warrant).


 


(c)                                  Certificate as to Adjustments.  In case of any adjustment or readjustment in
the price or kind of securities issuable on the exercise of this Warrant, the
Company will promptly give written notice thereof to the holder of this Warrant
in the form of a certificate, certified and confirmed by the Board of Directors
of the Company, setting forth such adjustment or readjustment and showing in
reasonable detail the facts upon which such adjustment or readjustment is
based.


 


(d)                                 The Company sells, grants or issues any shares, options, warrants, or
any instrument convertible into shares or equity in any form below the exercise
price per share of the warrant.  If
the Company, at any time while this Warrant is outstanding, shall issue any
additional shares of Common Stock (“Additional Shares”) (otherwise than as
provided in the foregoing subsections (a) and (b) of this Section 7),
to a party other than as contemplated in the Preferred Stock Purchase Agreement
between the Warrant Holder and the Company dated the date hereof at a price per
share that is less than the then current Exercise Price then in effect, or
without consideration, then the shares issuable upon exercise of this Warrant
shall be adjusted, as of the opening of business on the date of such issuance,
to that number determined by multiplying the shares issuable upon exercise of
this Warrant immediately prior thereto by a fraction:


 


(i)                                     the
numerator of which shall be equal to the number of shares of Common Stock
outstanding immediately after the issuance of such Additional Shares, and


 


(ii)                                  the
denominator of which shall be equal to the sum of (A) the number of shares
of Common Stock outstanding immediately prior to the issuance of such
Additional Shares plus (B) a number equal to the quotient obtained by
dividing (x) an amount equal to the aggregate consideration received by
the Company for the Additional Shares so issued by (y) the then current
Exercise Price.


 


In the event of an
adjustment to the number of shares the Exercise Price shall be adjusted to a
price equal to (a) the total number of shares issuable under this Warrant
prior to this adjustment being made under this Section 7(d) multiplied
by the Exercise Price then in effect, divided by (b) the number of shares
issuable upon exercise of this Warrant as adjusted under this Section 7(d)


 


The provisions of this
subsection (d) shall not apply under any of the circumstances for
which an adjustment is provided in subsections (a) or (b) of this Section 7.  No adjustment of the shares issuable upon
exercise of this Warrant shall be made under this subsection upon the
issuance of any Additional Shares which are issued pursuant to any Common Stock
Equivalent (defined below) if upon the issuance of such Common Stock Equivalent
any adjustment shall have been made pursuant to subsection (e) of
this Section 7.


 


5





















 


(e)                                  If
the Company shall, at any time while this Warrant is outstanding, issue any
convertible security, warrant, option or other right to purchase Additional
Shares (“Common Stock Equivalents”) and the price per share for which
Additional Shares may be issuable shall be less than the Exercise Price then in
effect, then the shares issuable upon exercise of this Warrant shall be
adjusted upon each such issuance or amendment as provided in subsection (d) of
this Section 7 on the basis that (i) the maximum number of Additional
Shares issuable pursuant to all such Common Stock Equivalents shall be deemed
to have been issued (whether or not such Common Stock Equivalents are actually
then exercisable, convertible or exchangeable in whole or in part) as of the
earlier of (A) the date on which the Company shall enter into a firm
contract for the issuance of such Common Stock Equivalent, or (B) the date
of actual issuance of such Common Stock Equivalent, and (ii) the aggregate
consideration received for such maximum number of Additional Shares shall be
deemed to be consideration received by the Company for the issuance of such
Additional Shares pursuant to such Common Stock Equivalent.  Notwithstanding anything to the contrary set
forth in this subsection, no adjustment of the Shares issuable upon exercise of
this Warrant shall be made as a result of or in connection with any Exempt
Issuance as defined in that certain Preferred Stock Purchase Agreement of even
date herewith between the Company and the Warrant Holder.


 


(i)                                     The
consideration received by the Company upon an issuance of Additional Shares or
Common Stock Equivalents shall be deemed to be the following:  To the extent that any Additional Shares or
any Common Stock Equivalents shall be issued for a cash consideration, the
consideration received by the Company therefor, or, if such Additional Shares
or Common Stock Equivalents are offered by the Company for subscription, the
subscription price, or, if such Additional Shares or Common Stock Equivalents
are sold to underwriters or dealers for public offering without a subscription
offering, the initial public offering price, in any such case excluding any
amounts paid or receivable for accrued interest or accrued dividends and
without deduction of any compensation, discounts, commissions, or expenses paid
or incurred by the Company for or in connection with the underwriting thereof
or otherwise in connection with the issue thereof.  The consideration for any Additional Shares
issuable pursuant to any Common Stock Equivalents shall be the consideration
received by the Company for issuing such Common Stock Equivalents, plus the
additional consideration payable to the Company upon the exercise, conversion
or exchange of such Common Stock Equivalents. 
In case of the issuance at any time of any Additional Shares or Common
Stock Equivalents in payment or satisfaction of any dividend upon any class of
capital stock other than common stock, the Company shall be deemed to have
received for such Additional Shares or Common Stock Equivalents consideration
equal to the amount of such dividend so paid or satisfied.  In any case in which the consideration to be
received or paid shall be other than cash, the board of directors shall
determine in good faith the fair market value of such consideration and
promptly notify the Warrant Holder of its determination of the fair market
value of such consideration prior to payment or accepting receipt thereof.


 


(ii)                                  Upon
the expiration or termination of the right to convert, exchange or exercise any
Common Stock Equivalent, the issuance of which effected an adjustment pursuant
to this Section 7, if such Common Stock Equivalent shall not have been
converted, exercised or exchanged in its entirety, the number of shares of
common stock deemed to be issued and outstanding by reason of the fact that
they were issuable upon conversion, exchange or exercise of any such Common
Stock Equivalent shall no longer be computed as set 


 


6





















 


forth above, and the Shares issuable upon exercise of
this Warrant shall forthwith be readjusted and thereafter be the number which
it would have been (but reflecting any other adjustments in the Shares issuable
upon exercise of this Warrant made pursuant to the provisions of this Section 7
after the issuance of such Common Stock Equivalent) had the adjustment of the
Shares issuable upon exercise of this Warrant been made in accordance with the
issuance or sale of the number of Additional Shares actually issued upon
conversion, exchange or issuance of such Common Stock Equivalent and thereupon
only the number of Additional Shares actually so issued and only the
consideration actually received by the Company (computed as in clause (i) of
this subsection) shall be deemed to have been received by the Company.


 


8.                                       Fractional Shares.  The Company shall not be required to issue or
cause to be issued fractional Warrant Shares on the exercise of this
Warrant.  The number of full Warrant
Shares that shall be issuable upon the exercise of this Warrant shall be
computed on the basis of the aggregate number of Warrants Shares purchasable on
exercise of this Warrant so presented. 
If any fraction of a Warrant Share would, except for the provisions of
this Section 8, be issuable on the exercise of this Warrant, the Company
shall, at its option, (i) pay an amount in cash equal to the Exercise
Price multiplied by such fraction or (ii) round the number of Warrant
Shares issuable up or down, as applicable, to the next whole number.


 


9.                                       Sale or Merger of the Company.  Upon a Change in Control, the restriction
contained in Section 6 shall immediately be released and the Warrant
Holder will have the right to exercise this Warrant concurrently with such
Change in Control event.  For purposes of
this Warrant, the term “Change in Control” shall mean a consolidation or merger
of the Company with or into another company or entity in which the Company is
not the surviving entity or the sale of all or substantially all of the assets
of the Company to another company or entity not controlled by the then existing
stockholders of the Company in a transaction or series of transactions.


 


10.                                 Notice of Intent to Sell or Merge the Company.  The Company will give Warrant Holder ten (10) business
days notice before the event of a sale of all or substantially all of the
assets of the Company or the merger or consolidation of the Company in a
transaction in which the Company is not the surviving entity.


 


11.                                 Issuance of Substitute Warrant.  In the event of a merger, consolidation,
recapitalization or reorganization of the Company or a reclassification of
Company shares of stock, which results in an adjustment to the number of shares
subject to this Warrant and/or the Exercise Price hereunder, the Company agrees
to issue to the Warrant Holder a substitute Warrant reflecting the adjusted
number of shares and/or Exercise Price upon the surrender of this Warrant to
the Company.


 


12.                                 Notice.  All notices and other communications
hereunder shall be in writing and shall be deemed to have been given (i) on
the date they are delivered if delivered in person; (ii) on the date
initially received if delivered by facsimile transmission followed by
registered or certified mail confirmation; (iii) on the date delivered by
an overnight courier service; or (iv) on the third business day after it
is mailed by registered or certified mail, return receipt requested with
postage and other fees prepaid as follows:


 


7





















 


If to the Company:


 


Corgenix Medical Corporation


12061 Tejon Street


Westminster, Colorado 80234


Attention: Chief Financial Officer


Facsimile: (303) 453-8958


 


If to the Warrant Holder:


 


Barron Partners LP


Barron Capital Advisors
LLC,


Managing Partner


Attn: Andrew Barron
Worden


730 Fifth Avenue, 9th
Floor


New York NY 10019


Tel: 212-659-7790


 


13.                                 Miscellaneous.


 


(a)                                  This
Warrant shall be binding on and inure to the benefit of the parties hereto and
their respective successors and permitted assigns.  This Warrant may be amended only by a writing
signed by the Company and the Warrant Holder; provided that the Company shall
not sign an amendment to this Warrant that has not been approved by the Board
of Directors of the Company and the holders of a majority of the shares of
Common Stock voting on such amendment, exclusive of shares held by officers and
directors of the Company and by the Warrant Holder.


 


(b)                                 Nothing
in this Warrant shall be construed to give to any person or corporation other
than the Company and the Warrant Holder any legal or equitable right, remedy or
cause of action under this Warrant; this Warrant shall be for the sole and
exclusive benefit of the Company and the Warrant Holder.


 


(c)                                  This
Warrant shall be governed by, construed and enforced in accordance with the internal
laws of the State of New York without regard to the principles of conflicts of
law thereof.


 


(d)                                 The
headings herein are for convenience only, do not constitute a part of this
Warrant and shall not be deemed to limit or affect any of the provisions
hereof.


 


(e)                                  In
case any one or more of the provisions of this Warrant shall be invalid or
unenforceable in any respect, the validity and enforceability of the remaining
terms and provisions of this Warrant shall not in any way be affected or
impaired thereby and the parties will attempt in good faith to agree upon a
valid and enforceable provision which shall be a commercially reasonably
substitute therefore, and upon so agreeing, shall incorporate such substitute
provision in this Warrant.


 


8





















 


(f)                                    The
Warrant Holder shall not, by virtue hereof, be entitled to any voting or other
rights of a shareholder of the Company, either at law or equity, and the rights
of the Warrant Holder are limited to those expressed in this Warrant.


 


[SIGNATURES
ON FOLLOWING PAGE]


 


9





















 


IN WITNESS WHEREOF, the
Company has caused this Warrant to be duly executed by the authorized officer
as of the date first above stated.


 


CORGENIX MEDICAL CORPORATION, a Nevada corporation


 


 


	
  By: 

  	
  /s/ Douglass T. Simpson

  	
   

  
	
  Name: Douglass T. Simpson

  
	
  Its: Chief Executive Officer

  



 


10





















 


FORM OF
ELECTION TO PURCHASE


 


(To be executed by the
Warrant Holder to exercise the right to purchase shares of Common Stock under
the foregoing Warrant)


 


To:  Corgenix Medical
Corporation:


 


In accordance with the
Warrant enclosed with this Form of Election to Purchase, the undersigned
hereby irrevocably elects to purchase                             
shares of Common Stock (“Common Stock”), $.001 par value, of Corgenix Medical
Corporation and encloses the warrant and $        
for each Warrant Share being purchased or an aggregate of $                                
in cash or certified or official bank check or checks, which sum represents the
aggregate Exercise Price (as defined in the Warrant) together with any
applicable taxes payable by the undersigned pursuant to the Warrant.


 


The undersigned requests
that certificates for the shares of Common Stock issuable upon this exercise be
issued in the name of:


 


	
   

  
	
   

  
	
   

  



(Please print name and address)


 


	
   

  



(Please insert Social
Security or Tax Identification Number)


 


If the number of shares
of Common Stock issuable upon this exercise shall not be all of the shares of
Common Stock which the undersigned is entitled to purchase in accordance with
the enclosed Warrant, the undersigned requests that a New Warrant (as defined
in the Warrant) evidencing the right to purchase the shares of Common Stock not
issuable pursuant to the exercise evidenced hereby be issued in the name of and
delivered to:


 


	
   

  
	
   

  
	
   

  



(Please print name and
address)


 


	
  Dated:

  	
   

  	
  Name of Warrant Holder:

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  (Print)

  	
   

  
	
   

  	
   

  	
  (By:)

  	
   

  
	
   

  	
   

  	
  (Name:)

  	
   

  
	
   

  	
   

  	
  (Title:)

  	
   

  
	
   

  	
   

  	
  Signature must conform in all respects to name of
  Warrant Holder as specified on the face of the Warrant

  
							



 


11